Su1060 Faldaprevir Plus Pegylated Interferon/Ribavirin Did Not Increase Anaemia Compared With Pegylated Interferon/Ribavirin in HCV Genotype-1, Treatment-Naïve Patients: Pooled Analysis of Phase III Studies
Year: 2014
Type: conference-abstract
Source: Gastroenterology
Authors: Tarik Asselah, Donald M. Jensen, Graham Foster, Mark Sulkowski, Denis Ouzan, Luis Morano, Robert Buynak, Kosh Agarwal, Tarek Hassanein, Daniel Forton, Francesco Negro, Daniel Genné, Kelly Kaita, Andreas Maieron, Liliana Preotescu, Christoph Sarrazin, Elmar Zehnter, Manuel Romero-Gomez, Jerry O. Stern, Anne-Marie Quinson, Murray Drulak, Miguel Garcia, Florian Voss, Wulf Böcher, Peter Ferenci
Language: English
Topic: Hepatitis C virus research
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2062949294